Top Page
Oneview Healthcare Chess Depository Interests repr 1
(OTC:ONE)
Oneview Healthcare Chess Depository Interests repr 1 (ONE) vs. iShares MSCI Australia ETF (EWA)
Oneview Healthcare Chess Depository Interests repr 1 Business Overview & Revenue Model
Oneview Healthcare Chess Depository Interests repr 1 Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.57M | 9.89M | 9.40M | 8.92M | 9.73M | 7.10M |
| Gross Profit | 7.11M | 6.67M | 6.16M | 5.35M | 5.31M | 4.72M |
| EBITDA | -12.01M | -11.26M | -7.88M | -12.09M | -8.01M | -7.44M |
| Net Income | -13.23M | -10.84M | -8.93M | -10.87M | -8.19M | -9.45M |
Balance Sheet | ||||||
| Total Assets | 16.15M | 25.96M | 21.92M | 12.75M | 21.09M | 14.25M |
| Cash, Cash Equivalents and Short-Term Investments | 8.19M | 13.83M | 11.55M | 6.41M | 15.18M | 6.80M |
| Total Debt | 979.00K | 1.15M | 935.32K | 543.01K | 1.20M | 1.51M |
| Total Liabilities | 8.65M | 12.71M | 12.78M | 10.50M | 11.19M | 10.18M |
| Stockholders Equity | 7.50M | 13.25M | 9.14M | 2.26M | 9.90M | 4.07M |
Cash Flow | ||||||
| Free Cash Flow | -10.11M | -10.52M | -7.79M | -10.24M | -4.09M | -7.94M |
| Operating Cash Flow | -10.06M | -10.47M | -7.26M | -10.20M | -4.03M | -7.69M |
| Investing Cash Flow | -142.66K | -459.78K | -521.38K | -44.52K | -65.26K | -249.35K |
| Financing Cash Flow | 12.99M | 13.14M | 13.04M | -100.11K | 12.22M | 5.07M |
Oneview Healthcare Chess Depository Interests repr 1 Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1 Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | AU$471.97M | 30.05 | 22.84% | 0.73% | 21.47% | 89.09% | |
| ― | AU$127.58M | 79.17 | 1.89% | ― | 10.06% | ― | |
| ― | AU$100.20M | ― | -8647.54% | ― | 25.98% | 21.43% | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | $70.49M | ― | -12.35% | ― | 15.99% | 22.05% | |
| ― | AU$61.03M | -9.86 | -13.83% | ― | 3.61% | -17.03% | |
| ― | AU$148.85M | ― | ― | ― | 21.56% | -24.08% |
Oneview Healthcare Chess Depository Interests repr 1 Corporate Events
Oneview Healthcare PLC has announced the application for the quotation of 905,619 CHESS Depositary Interests on the Australian Securities Exchange. This move indicates the company’s ongoing efforts to enhance its market presence and provide liquidity options for its stakeholders, potentially impacting its operational capabilities and industry positioning positively.
The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.
Oneview Healthcare PLC announced the cessation of 50,000 restricted share units due to unmet conditions, reflecting a lapse in conditional rights. This development may impact the company’s capital structure and investor perception, highlighting challenges in meeting certain operational or strategic conditions.
The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.
Oneview Healthcare PLC announced the cessation of 267,900 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could have implications for its market positioning and stakeholder interests.
The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.
Oneview Healthcare PLC announced the cessation of 212,723 restricted share units due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This development may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational and financial strategies.
The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.
Oneview Healthcare PLC has announced a new quotation of 531,000 CHESS Depositary Interests on the Australian Securities Exchange, effective September 2, 2025. This move indicates a strategic step to enhance liquidity and potentially attract more investors, reflecting the company’s ongoing efforts to strengthen its market position and expand its financial capabilities.
The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.34 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.
Oneview Healthcare PLC is a company specializing in the development and sale of software and hardware solutions for the healthcare sector, with operations in the USA, Ireland, Thailand, and Australia. In its latest earnings report for the first half of 2025, Oneview Healthcare PLC reported a 36% increase in revenue to €6.3 million compared to the same period last year, driven by strong deployment activity and new customer acquisitions. However, the company also experienced a higher net loss of €7.9 million, attributed to unfavorable foreign exchange movements and increased staff costs. Key highlights include the launch of an AI-powered Virtual Patient Assistant and a strategic restructuring to improve operational efficiency, resulting in a 10% reduction in global headcount. Looking forward, the company remains optimistic about its sales pipeline and expects cost savings from recent restructuring efforts to materialize in the second half of the year, supporting its goal of achieving operational efficiency and sustained growth.
Oneview Healthcare PLC has released a presentation containing general information about its current activities as of August 13, 2025. The presentation, which includes financial information prepared in accordance with IFRS, is intended for general informational purposes and not as investment advice. It highlights the company’s focus on maintaining transparency with stakeholders, while also acknowledging the inherent risks and uncertainties in the healthcare market that could impact future performance.
The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.
Oneview Healthcare PLC reported a 36% increase in total revenue for the six-month period ending June 30, 2025, driven by a significant rise in non-recurring revenue. Despite the revenue growth, the company experienced a 44% increase in net loss compared to the previous year, and no dividends were declared for the period. The increase in securities issued and net tangible assets per security indicates a strategic focus on growth, although the financial results highlight ongoing challenges in achieving profitability.
The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.
Oneview Healthcare reported a decrease in cash balance and a net cash outflow for Q2 2025, influenced by restructuring costs and unfavorable R&D tax credit timing. Despite these challenges, the company saw a significant increase in customer cash receipts and secured new contracts, including a three-year extension with a major client. The company is expanding its virtual care support and launching new personalized patient interfaces, which are expected to strengthen its market position and operational capabilities.
The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.
Oneview Healthcare PLC has announced that it will release its half-year results for the period ending June 30, 2025, on August 13, 2025. The company will host a conference call on the same day for investors and analysts, led by CEO James Fitter and CFO Darragh Lyons. This announcement is part of Oneview’s ongoing efforts to keep stakeholders informed and engaged, potentially impacting its market positioning and stakeholder relations.
The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.